RE:RE:RE:RE:RE:Multiplewildbird1 wrote: chry200030 wrote: Yeah... Can wait 5 years for $50. But doubt it takes that long.
Watch what happens when we get BTD. coming shortly..!
chry200030...you will find this link interesting, the author(he has 38 years experience in high tech & biotech) discuss what happen after a company get BTD approval.
https://seekingalpha.com/article/4314267-real-value-of-breakthrough-therapy-designation In the first paragraph it is said " BTD usually increase valuation
significantly". In the last paragraph under "Investment summary".
It is said " It is clear that getting a BTD adds significant value to a company. Based on historical averages, a
pure play company with a BTD for a
significant population could be worth $8.3 billion ".
1) TLT is a pure play company(specialize in cancer treatments).
2) Bladder cancer has a significant population(573,000 new patients worldwide each year).
$8 billion is a very big number, but if the BCG shortage persist and because TLT-Ruvidar has no side effects and can treat 100% of patients(no restrictions), TLT could get a resonable chunk of this $8 billion.
BTD will certainly get more eyeballs on TLT, and yes, $$ will be easier. At least in the short term. I think most here are interested in the short term. In the long term they still have to prove some things but AA will solve most of that. No Idea when AA will happen but ptobably later this year. BTD will definetly make Dr. LBiati's job easier in setting up some sort of deal for TLT. And THAT WILL move the SPˆˆˆ